Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02048072
What this trial is testing

Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS

Who this might be right for
Multiple SclerosisAutonomic Nervous System Dysfunction
Jochen Vehoff 33
Not applicableStudy completedNCT04934800
What this trial is testing

Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)

Who this might be right for
Multiple Sclerosis
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 256
Large-scale testing (Phase 3)Ended earlyNCT00731692
What this trial is testing

This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS.

Who this might be right for
Primary Progressive Multiple Sclerosis
Novartis Pharmaceuticals 970
Not applicableStudy completedNCT04371575
What this trial is testing

Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 Patients

Who this might be right for
Trigeminal NeuralgiaMultiple SclerosisPain, Neuropathic
Stine Maarbjerg, MD PhD 60
Not applicableStudy completedNCT04707144
What this trial is testing

Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5T

Who this might be right for
Multiple Sclerosis
Fondation Ophtalmologique Adolphe de Rothschild 106
Not applicableStudy completedNCT01356134
What this trial is testing

Vascular Fundus Changes in Patients With High Probability of Chronic Cerebrospinal Venous Insufficiency (CCSVI)

Who this might be right for
Ehlers-Danlos SyndromeMultiple Sclerosis
Genetic Disease Investigators 60
Not applicableStudy completedNCT04289909
What this trial is testing

Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)

Who this might be right for
Relapsing Remitting Multiple SclerosisProgressive Multiple SclerosisOptic Neuritis+4 more
Institut National de la Santé Et de la Recherche Médicale, France 50
Not applicableEnrolling By InvitationNCT07564921
What this trial is testing

Nutritional Status and Muscle Function in Ambulatory Multiple Sclerosis Patients With Dysphagia

Who this might be right for
Multiple SclerosisNutritionSwallowing
Sanko University 34
Not applicableUnknownNCT02264704
What this trial is testing

Exercise Intensity and Immune Function in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of the West of Scotland 63
Not applicableStudy completedNCT04386863
What this trial is testing

Taxonomy of Neurorehabilitation Treatments and Outcome Measures: a Multicentre Italian Study

Who this might be right for
Multiple SclerosisStrokeParkinson Disease
Fondazione Don Carlo Gnocchi ETS 204
Not applicableUnknownNCT05451069
What this trial is testing

Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and Plasmacytoid Dendritic Cells in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Assiut University 42
Large-scale testing (Phase 3)Study completedNCT01489254
What this trial is testing

Efficacy and Safety of GTR in Comparison to Copaxone®

Who this might be right for
Multiple Sclerosis
Synthon BV 794
Not applicableWithdrawnNCT01071694
What this trial is testing

QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in Korea

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bayer
Post-approval studies (Phase 4)Study completedNCT01888354
What this trial is testing

Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations

Who this might be right for
Multiple Sclerosis (MS)
The University of Texas Health Science Center, Houston 25
Not applicableLooking for participantsNCT07183683
What this trial is testing

Stimulation of Acupuncture Points in Female Patients With Multiple Sclerosis and Neurogenic Bladder Dysfunction

Who this might be right for
Neurogenic Bladder Dysfunction
Charite University, Berlin, Germany 150
Not applicableLooking for participantsNCT07174973
What this trial is testing

Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis

Who this might be right for
Multiple SclerosisMobility LimitationBalance; Distorted+1 more
University Health Network, Toronto 24
Not applicableUnknownNCT03444454
What this trial is testing

Telerehabilitation in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Fondazione Don Carlo Gnocchi ETS 136
Not applicableStudy completedNCT01704183
What this trial is testing

Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis

Who this might be right for
Relapse-remitting Multiple Sclerosis
Kuopio University Hospital 27
Testing effectiveness (Phase 2)Study completedNCT00245622
What this trial is testing

Autologous T Cell Vaccine (TCV) for Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Opexa Therapeutics, Inc. 150
Not applicableStudy completedNCT02340754
What this trial is testing

Mindfulness-based Stress Reduction for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National University of Natural Medicine 67
Next Page